Validated list of key drug-drug interactions that affect older adults published
By
Alicia Lasek
Oct 14, 2021
The list, published Wednesday in JAMDA, includes 66 drug-drug interactions that are commonly problematic for older adults, and can be used as a clinical management tool to assess potential harms.
Cases of life-threatening ‘broken heart syndrome’ rising among older women: AHA
By
Alicia Lasek
Oct 14, 2021
Takotsubo syndrome (TTS), a dangerous condition that can weaken heart muscle, has seen a steady increase among Americans, especially older women, a new study reveals.
Nursing home residents may have better CPR outcomes than their community-dwelling peers: study
By
Alicia Lasek
Oct 14, 2021
Withholding vigorous treatment for cardiac arrest solely based on nursing home residential status is not justified, researchers say.
Clinical briefs for Thursday, Oct. 14
By
Alicia Lasek
Oct 14, 2021
New CDC effort will track impact of COVID-19 and other public health threats on long-term care facilities … FDA pushes to cut sodium by 12% in American foods in bid to confront chronic disease epidemic...
CDC: Senior care challenges ahead as nearly one-half of U.S. older adults say they have arthritis
By
Alicia Lasek
Oct 13, 2021
The number of adults with activity-limiting arthritis is growing, especially among seniors, according to a new analysis of national survey data.
Poorly controlled diabetes — not diabetes itself — triples dementia risk, study finds
By
Alicia Lasek
Oct 13, 2021
In the absence of a cure for dementia, prevention is vital, and a new study offers evidence that this can be done through the careful control of diabetes, investigators say.
Seniors should not begin taking aspirin to prevent heart disease: New U.S. guidance
By
Alicia Lasek
Oct 13, 2021
The risk of bleeding caused by aspirin in adults age 60 and older cancels out the benefits of preventing heart disease, an influential U.S. task force stated Tuesday.
Clinical briefs for Wednesday, Oct. 13
By
Alicia Lasek
Oct 13, 2021
Governor bans vaccine mandates by ‘any entity’ in Texas … Moderna’s COVID-19 vaccine may not meet booster dose criteria, FDA scientists say … A wrenching farewell: Bidding adieu to my primary...
Alzheimer’s drug designed for ‘at-home’ use scores FDA breakthrough designation
By
Alicia Lasek
Oct 12, 2021
The experimental Alzheimer’s drug gantenerumab is the “first and only” anti-amyloid antibody being investigated for subcutaneous administration and could potentially be given to patients...
Feds asked to OK what could be the first COVID-19 antiviral pill
By
Alicia Lasek
Oct 12, 2021
If authorized for emergency use, certain patients could take molnupiravir at home after COVID-19 diagnosis, the drug’s developers said.